COMMUNIQUÉS West-GlobeNewswire

Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update

26/02/2019 - 08:00

LONDON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund

26/02/2019 - 07:17

Amsterdam, The Netherlands – 26 February 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) announces today a EUR 280,000 private placement of 28 convertible notes with a principal amount of EUR 10,000 each (the “ Notes [...]

Biocartis Group NV: Biocartis Places Its 1,000th Idylla(TM) Instrument with Geisinger in US

26/02/2019 - 07:01

PRESS RELEASE: 26 February 2019, 07:00 CET Biocartis Places Its 1,000 th Idylla(TM) Instrument with Geisinger in US Mechelen, Belgium, 26 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]

IBA DÉCLARATION INTERMÉDIAIRE

26/02/2019 - 07:00

IBA Déclaration Intermédiaire Retour à la profitabilité au deuxième semestre 2018 Louvain-la-Neuve, Belgique, 26 février 2019 – IBA ( Ion Beam Applications SA ), le premier fournisseur mondial de solutions de [...]

IBA Trading Update

26/02/2019 - 07:00

IBA Trading Update Return to net profitability in H2 Louvain-La-Neuve, Belgium, February 26, 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment [...]

Dr. Amir Bajoghli Recognized as Top Doctor in Dermatology by Northern Virginia Magazine

26/02/2019 - 05:16

MCLEAN, Va., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Dr. Bajoghli of the Skin and Laser Surgery Center has once more been awarded recognition as a Top Doctor in Dermatology and MOHS Surgery for 2019, by Northern Virginia [...]

Novartis issues summary financial information for the Alcon eye care business ahead of shareholder vote on proposed spin-off

25/02/2019 - 23:56

Basel, February 25, 2019 - Novartis today published certain key financial information for the Alcon eye care business covering the full year 2018 ahead of a vote on the proposed 100% spin-off of Alcon at the Novartis [...]

Sanofi : Sanofi and Regeneron strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies

25/02/2019 - 23:16

Sanofi and Regeneron strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies Praluent ® (alirocumab) continues to be available in the U.S. PARIS and TARRYTOWN, NY - [...]

Sanofi : Sanofi et Regeneron sont en profond désaccord avec le verdict confirmant trois des cinq brevets américains d'Amgen relatifs aux anticorps PCSK9

25/02/2019 - 23:16

Sanofi et Regeneron sont en profond désaccord avec le verdict confirmant trois des cinq brevets américains d'Amgen relatifs aux anticorps PCSK9 Praluent ® (alirocumab) continue d'être disponible aux Etats-Unis Paris et [...]

MacroGenics Announces Participation in SVB Leerink Global Healthcare Conference

25/02/2019 - 23:00

ROCKVILLE, MD, Feb. 25, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Antares Pharma to Report Fourth Quarter and Full Year 2018 Financial and Operating Results

25/02/2019 - 23:00

EWING, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2018 financial results and recent operating progress before the market [...]

R1 RCM to Present at the Cowen and Company 39th Annual Health Care Conference

25/02/2019 - 23:00

CHICAGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]

PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call

25/02/2019 - 22:30

HOUSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ 325 [...]

Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program

25/02/2019 - 22:30

BATON ROUGE, La., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized [...]

ReWalk Robotics Announces Closing of $4.37 Million Public Offering

25/02/2019 - 22:30

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 25, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing and funding of its previously announced [...]

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019

25/02/2019 - 22:05

Conference Call to Discuss Results on March 7, 2019 at 8:00 a.m. ET WARSAW, Indiana, Feb. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively [...]

Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development

25/02/2019 - 22:05

Publication Highlights That IV Meloxicam Has a Safety Profile Similar to Placebo and Reduces Opioid Consumption MALVERN, Pa., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating [...]

Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update

25/02/2019 - 22:05

MENLO PARK, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]

Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update

25/02/2019 - 22:05

Webcast and Conference Call to be Held at 4:30 p.m. EST on March 4, 2019 SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]